UniProt ID | EF2K_HUMAN | |
---|---|---|
UniProt AC | O00418 | |
Protein Name | Eukaryotic elongation factor 2 kinase | |
Gene Name | EEF2K | |
Organism | Homo sapiens (Human). | |
Sequence Length | 725 | |
Subcellular Localization | ||
Protein Description | Threonine kinase that regulates protein synthesis by controlling the rate of peptide chain elongation. Upon activation by a variety of upstream kinases including AMPK or TRPM7, phosphorylates the elongation factor EEF2 at a single site, renders it unable to bind ribosomes and thus inactive. In turn, the rate of protein synthesis is reduced.. | |
Protein Sequence | MADEDLIFRLEGVDGGQSPRAGHDGDSDGDSDDEEGYFICPITDDPSSNQNVNSKVNKYYSNLTKSERYSSSGSPANSFHFKEAWKHAIQKAKHMPDPWAEFHLEDIATERATRHRYNAVTGEWLDDEVLIKMASQPFGRGAMRECFRTKKLSNFLHAQQWKGASNYVAKRYIEPVDRDVYFEDVRLQMEAKLWGEEYNRHKPPKQVDIMQMCIIELKDRPGKPLFHLEHYIEGKYIKYNSNSGFVRDDNIRLTPQAFSHFTFERSGHQLIVVDIQGVGDLYTDPQIHTETGTDFGDGNLGVRGMALFFYSHACNRICESMGLAPFDLSPRERDAVNQNTKLLQSAKTILRGTEEKCGSPQVRTLSGSRPPLLRPLSENSGDENMSDVTFDSLPSSPSSATPHSQKLDHLHWPVFSDLDNMASRDHDHLDNHRESENSGDSGYPSEKRGELDDPEPREHGHSYSNRKYESDEDSLGSSGRVCVEKWNLLNSSRLHLPRASAVALEVQRLNALDLEKKIGKSILGKVHLAMVRYHEGGRFCEKGEEWDQESAVFHLEHAANLGELEAIVGLGLMYSQLPHHILADVSLKETEENKTKGFDYLLKAAEAGDRQSMILVARAFDSGQNLSPDRCQDWLEALHWYNTALEMTDCDEGGEYDGMQDEPRYMMLAREAEMLFTGGYGLEKDPQRSGDLYTQAAEAAMEAMKGRLANQYYQKAEEAWAQMEE | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MADEDLIFR ------CCCCCEEEE | 28.97 | 22223895 | |
18 | Phosphorylation | EGVDGGQSPRAGHDG ECCCCCCCCCCCCCC | 21.45 | 19664994 | |
27 | Phosphorylation | RAGHDGDSDGDSDDE CCCCCCCCCCCCCCC | 49.36 | 26503892 | |
31 | Phosphorylation | DGDSDGDSDDEEGYF CCCCCCCCCCCCCEE | 53.11 | 26503892 | |
37 | Phosphorylation | DSDDEEGYFICPITD CCCCCCCEEEEECCC | 7.95 | 23927012 | |
43 | Phosphorylation | GYFICPITDDPSSNQ CEEEEECCCCCCCCC | 21.35 | 23927012 | |
47 | Phosphorylation | CPITDDPSSNQNVNS EECCCCCCCCCCHHH | 49.25 | 23927012 | |
48 | Phosphorylation | PITDDPSSNQNVNSK ECCCCCCCCCCHHHH | 48.07 | 23927012 | |
54 | Phosphorylation | SSNQNVNSKVNKYYS CCCCCHHHHHHHHHH | 33.43 | 23927012 | |
58 | Ubiquitination | NVNSKVNKYYSNLTK CHHHHHHHHHHCCCH | 48.86 | 29967540 | |
59 | Phosphorylation | VNSKVNKYYSNLTKS HHHHHHHHHHCCCHH | 13.61 | 28796482 | |
60 | Phosphorylation | NSKVNKYYSNLTKSE HHHHHHHHHCCCHHH | 7.84 | 28796482 | |
61 | Phosphorylation | SKVNKYYSNLTKSER HHHHHHHHCCCHHHH | 23.44 | 28796482 | |
65 | Ubiquitination | KYYSNLTKSERYSSS HHHHCCCHHHHCCCC | 54.18 | 22817900 | |
66 | Phosphorylation | YYSNLTKSERYSSSG HHHCCCHHHHCCCCC | 23.28 | 25159151 | |
69 | Phosphorylation | NLTKSERYSSSGSPA CCCHHHHCCCCCCCC | 14.62 | 23927012 | |
70 | Phosphorylation | LTKSERYSSSGSPAN CCHHHHCCCCCCCCC | 25.01 | 25463755 | |
71 | Phosphorylation | TKSERYSSSGSPANS CHHHHCCCCCCCCCH | 29.77 | 25463755 | |
72 | Phosphorylation | KSERYSSSGSPANSF HHHHCCCCCCCCCHH | 37.03 | 22167270 | |
74 | Phosphorylation | ERYSSSGSPANSFHF HHCCCCCCCCCHHHH | 23.84 | 22167270 | |
78 | Phosphorylation | SSGSPANSFHFKEAW CCCCCCCHHHHHHHH | 23.39 | 15024086 | |
82 | Ubiquitination | PANSFHFKEAWKHAI CCCHHHHHHHHHHHH | 37.64 | 29967540 | |
86 | Ubiquitination | FHFKEAWKHAIQKAK HHHHHHHHHHHHHHH | 30.15 | 29967540 | |
93 | Ubiquitination | KHAIQKAKHMPDPWA HHHHHHHHCCCCCCH | 47.69 | 29967540 | |
132 | Ubiquitination | LDDEVLIKMASQPFG CCHHHHHHHHCCCCC | 25.01 | - | |
135 | Phosphorylation | EVLIKMASQPFGRGA HHHHHHHCCCCCHHH | 34.58 | 22817900 | |
151 | Ubiquitination | RECFRTKKLSNFLHA HHHHHHHHHHHHHHH | 57.44 | 29967540 | |
162 | Ubiquitination | FLHAQQWKGASNYVA HHHHHHCCCCHHHHH | 40.02 | 21906983 | |
170 | Ubiquitination | GASNYVAKRYIEPVD CCHHHHHHHHCCCCC | 35.37 | 29967540 | |
178 | Methylation | RYIEPVDRDVYFEDV HHCCCCCCCCCHHHH | 35.21 | - | |
202 | Ubiquitination | GEEYNRHKPPKQVDI HHHHHCCCCCCCCCE | 60.83 | 29967540 | |
223 | Ubiquitination | ELKDRPGKPLFHLEH EECCCCCCCCEEEEE | 41.03 | 29967540 | |
235 | Ubiquitination | LEHYIEGKYIKYNSN EEEEECCEEEEECCC | 30.89 | 22817900 | |
236 | Phosphorylation | EHYIEGKYIKYNSNS EEEECCEEEEECCCC | 17.32 | 22817900 | |
238 | Ubiquitination | YIEGKYIKYNSNSGF EECCEEEEECCCCCC | 34.98 | 21890473 | |
239 | Phosphorylation | IEGKYIKYNSNSGFV ECCEEEEECCCCCCC | 17.79 | 23312004 | |
241 | Phosphorylation | GKYIKYNSNSGFVRD CEEEEECCCCCCCCC | 29.32 | 29214152 | |
243 | Phosphorylation | YIKYNSNSGFVRDDN EEEECCCCCCCCCCC | 33.17 | 29214152 | |
340 | Phosphorylation | RDAVNQNTKLLQSAK HHHHHHHHHHHHHHH | 17.19 | - | |
341 | Ubiquitination | DAVNQNTKLLQSAKT HHHHHHHHHHHHHHH | 55.54 | 21906983 | |
345 | Phosphorylation | QNTKLLQSAKTILRG HHHHHHHHHHHHHHC | 31.53 | 26055452 | |
347 | Ubiquitination | TKLLQSAKTILRGTE HHHHHHHHHHHHCCH | 41.15 | 22817900 | |
347 | Acetylation | TKLLQSAKTILRGTE HHHHHHHHHHHHCCH | 41.15 | 25953088 | |
348 | Phosphorylation | KLLQSAKTILRGTEE HHHHHHHHHHHCCHH | 25.59 | 23401153 | |
353 | Phosphorylation | AKTILRGTEEKCGSP HHHHHHCCHHHHCCC | 34.24 | 30266825 | |
359 | Phosphorylation | GTEEKCGSPQVRTLS CCHHHHCCCCCCCCC | 22.94 | 30266825 | |
364 | Phosphorylation | CGSPQVRTLSGSRPP HCCCCCCCCCCCCCC | 26.81 | 23909892 | |
366 | Phosphorylation | SPQVRTLSGSRPPLL CCCCCCCCCCCCCCC | 33.82 | 15024086 | |
368 | Phosphorylation | QVRTLSGSRPPLLRP CCCCCCCCCCCCCCC | 37.93 | 23312004 | |
377 | Phosphorylation | PPLLRPLSENSGDEN CCCCCCCCCCCCCCC | 37.10 | 15024086 | |
380 | Phosphorylation | LRPLSENSGDENMSD CCCCCCCCCCCCCCC | 43.50 | 23909892 | |
386 | Phosphorylation | NSGDENMSDVTFDSL CCCCCCCCCCCCCCC | 40.28 | 25137130 | |
389 | Phosphorylation | DENMSDVTFDSLPSS CCCCCCCCCCCCCCC | 27.07 | 25137130 | |
392 | Phosphorylation | MSDVTFDSLPSSPSS CCCCCCCCCCCCCCC | 37.68 | 30576142 | |
395 | Phosphorylation | VTFDSLPSSPSSATP CCCCCCCCCCCCCCC | 61.24 | 25137130 | |
396 | Phosphorylation | TFDSLPSSPSSATPH CCCCCCCCCCCCCCC | 27.19 | 15024086 | |
398 | Phosphorylation | DSLPSSPSSATPHSQ CCCCCCCCCCCCCCC | 34.26 | 15024086 | |
399 | Phosphorylation | SLPSSPSSATPHSQK CCCCCCCCCCCCCCC | 39.28 | 30576142 | |
401 | Phosphorylation | PSSPSSATPHSQKLD CCCCCCCCCCCCCCC | 24.39 | 26074081 | |
404 | Phosphorylation | PSSATPHSQKLDHLH CCCCCCCCCCCCCCC | 30.16 | 27251275 | |
416 | Phosphorylation | HLHWPVFSDLDNMAS CCCCCCCCCHHHHHH | 37.18 | - | |
435 | Phosphorylation | HLDNHRESENSGDSG CHHCCCCCCCCCCCC | 41.87 | 23927012 | |
438 | Phosphorylation | NHRESENSGDSGYPS CCCCCCCCCCCCCCC | 39.67 | 23927012 | |
441 | Phosphorylation | ESENSGDSGYPSEKR CCCCCCCCCCCCHHC | 43.69 | 23927012 | |
443 | Phosphorylation | ENSGDSGYPSEKRGE CCCCCCCCCCHHCCC | 13.92 | 23927012 | |
445 | Phosphorylation | SGDSGYPSEKRGELD CCCCCCCCHHCCCCC | 47.46 | 23401153 | |
447 | Ubiquitination | DSGYPSEKRGELDDP CCCCCCHHCCCCCCC | 70.78 | - | |
462 | Phosphorylation | EPREHGHSYSNRKYE CCCCCCCCCCCCCCC | 34.54 | 30242111 | |
464 | Ubiquitination | REHGHSYSNRKYESD CCCCCCCCCCCCCCC | 32.92 | 22053931 | |
464 | Phosphorylation | REHGHSYSNRKYESD CCCCCCCCCCCCCCC | 32.92 | 27251275 | |
467 | Sumoylation | GHSYSNRKYESDEDS CCCCCCCCCCCCCCC | 58.58 | - | |
467 | Sumoylation | GHSYSNRKYESDEDS CCCCCCCCCCCCCCC | 58.58 | - | |
468 | Phosphorylation | HSYSNRKYESDEDSL CCCCCCCCCCCCCCC | 19.89 | 22167270 | |
470 | Phosphorylation | YSNRKYESDEDSLGS CCCCCCCCCCCCCCC | 43.12 | 22167270 | |
474 | Phosphorylation | KYESDEDSLGSSGRV CCCCCCCCCCCCCCC | 32.36 | 22167270 | |
477 | Phosphorylation | SDEDSLGSSGRVCVE CCCCCCCCCCCCHHH | 34.61 | 23927012 | |
478 | Phosphorylation | DEDSLGSSGRVCVEK CCCCCCCCCCCHHHH | 28.90 | 23927012 | |
485 | Ubiquitination | SGRVCVEKWNLLNSS CCCCHHHHHCCCCCC | 22.45 | 23000965 | |
491 | Phosphorylation | EKWNLLNSSRLHLPR HHHCCCCCCCCCCCH | 19.46 | 25159151 | |
492 | Phosphorylation | KWNLLNSSRLHLPRA HHCCCCCCCCCCCHH | 37.48 | 30576142 | |
500 | Phosphorylation | RLHLPRASAVALEVQ CCCCCHHHHHHHHHH | 25.26 | 26329039 | |
516 | Ubiquitination | LNALDLEKKIGKSIL HCCCCHHHHHCHHHH | 57.92 | - | |
517 | Ubiquitination | NALDLEKKIGKSILG CCCCHHHHHCHHHHC | 47.52 | 29967540 | |
520 | Ubiquitination | DLEKKIGKSILGKVH CHHHHHCHHHHCCCE | 37.48 | 29967540 | |
521 | Phosphorylation | LEKKIGKSILGKVHL HHHHHCHHHHCCCEE | 20.17 | 21712546 | |
582 | Ubiquitination | SQLPHHILADVSLKE HCCCHHHHCCCCCCC | 2.64 | 21890473 | |
596 | Ubiquitination | ETEENKTKGFDYLLK CCHHHHCCCHHHHHH | 60.22 | 29967540 | |
600 | Phosphorylation | NKTKGFDYLLKAAEA HHCCCHHHHHHHHHC | 16.21 | 20068231 | |
603 | Ubiquitination | KGFDYLLKAAEAGDR CCHHHHHHHHHCCCC | 42.85 | 21906983 | |
622 | Phosphorylation | LVARAFDSGQNLSPD EEEEECCCCCCCCHH | 35.51 | 22468782 | |
627 | Phosphorylation | FDSGQNLSPDRCQDW CCCCCCCCHHHHHHH | 32.10 | 21815630 | |
684 | Ubiquitination | TGGYGLEKDPQRSGD HCCCCCCCCCCCCCC | 78.67 | 23503661 | |
689 | Phosphorylation | LEKDPQRSGDLYTQA CCCCCCCCCCHHHHH | 31.26 | 29759185 | |
693 | Phosphorylation | PQRSGDLYTQAAEAA CCCCCCHHHHHHHHH | 11.10 | 29759185 | |
694 | Phosphorylation | QRSGDLYTQAAEAAM CCCCCHHHHHHHHHH | 21.01 | 28787133 | |
705 | Ubiquitination | EAAMEAMKGRLANQY HHHHHHHHHHHHHHH | 48.18 | 23503661 | |
712 | Phosphorylation | KGRLANQYYQKAEEA HHHHHHHHHHHHHHH | 13.99 | 27642862 | |
713 | Phosphorylation | GRLANQYYQKAEEAW HHHHHHHHHHHHHHH | 8.18 | 27642862 | |
715 | Ubiquitination | LANQYYQKAEEAWAQ HHHHHHHHHHHHHHH | 41.46 | - | |
723 | Sulfoxidation | AEEAWAQMEE----- HHHHHHHHCC----- | 4.89 | 30846556 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
61 | S | Phosphorylation | Kinase | EEF2K | O00418 | PSP |
66 | S | Phosphorylation | Kinase | EEF2K | O00418 | PSP |
72 | S | Phosphorylation | Kinase | MTOR | P42345 | PSP |
74 | S | Phosphorylation | Kinase | MTOR | P42345 | PSP |
78 | S | Phosphorylation | Kinase | AMPK_GROUP | - | PhosphoELM |
78 | S | Phosphorylation | Kinase | CHAK1 | Q96QT4 | PSP |
78 | S | Phosphorylation | Kinase | AMPK-FAMILY | - | GPS |
78 | S | Phosphorylation | Kinase | EEF2K | O00418 | PSP |
348 | T | Phosphorylation | Kinase | EEF2K | O00418 | PSP |
353 | T | Phosphorylation | Kinase | EEF2K | O00418 | PSP |
359 | S | Phosphorylation | Kinase | CDK1 | P06493 | Uniprot |
359 | S | Phosphorylation | Kinase | MK13 | O15264 | PhosphoELM |
359 | S | Phosphorylation | Kinase | P38D | O15264 | PSP |
366 | S | Phosphorylation | Kinase | RSK-SUBFAMILY | - | GPS |
366 | S | Phosphorylation | Kinase | AMPK_GROUP | - | PhosphoELM |
366 | S | Phosphorylation | Kinase | P70-SUBFAMILY | - | GPS |
366 | S | Phosphorylation | Kinase | AMPK-FAMILY | - | GPS |
366 | S | Phosphorylation | Kinase | EEF2K | O00418 | PSP |
366 | S | Phosphorylation | Kinase | P90RSK | Q15418 | PSP |
366 | S | Phosphorylation | Kinase | P70S6K | P23443 | PSP |
366 | S | Phosphorylation | Kinase | RPS6KB2 | Q9UBS0 | GPS |
366 | S | Phosphorylation | Kinase | P70S6K_GROUP | - | PhosphoELM |
366 | S | Phosphorylation | Kinase | RSK_GROUP | - | PhosphoELM |
377 | S | Phosphorylation | Kinase | MAPKAPK3 | Q16644 | GPS |
377 | S | Phosphorylation | Kinase | MAPKAPK5 | Q8IW41 | GPS |
377 | S | Phosphorylation | Kinase | MAPK2 | P49137 | PhosphoELM |
396 | S | Phosphorylation | Kinase | MAPK13 | O15264 | GPS |
396 | S | Phosphorylation | Kinase | MAPK14 | Q16539 | GPS |
396 | S | Phosphorylation | Kinase | MAPK11 | Q15759 | GPS |
396 | S | Phosphorylation | Kinase | EEF2K | O00418 | PSP |
398 | S | Phosphorylation | Kinase | PRKAA1 | Q13131 | GPS |
398 | S | Phosphorylation | Kinase | AMPK_GROUP | - | PhosphoELM |
398 | S | Phosphorylation | Kinase | PRKAA2 | P54646 | GPS |
398 | S | Phosphorylation | Kinase | AMPK-FAMILY | - | GPS |
398 | S | Phosphorylation | Kinase | AMPK | Q9Y478 | Uniprot |
441 | S | Phosphorylation | Kinase | EEF2K | O00418 | PSP |
445 | S | Phosphorylation | Kinase | EEF2K | O00418 | PSP |
474 | S | Phosphorylation | Kinase | EEF2K | O00418 | PSP |
491 | S | Phosphorylation | Kinase | EEF2K | O00418 | PSP |
500 | S | Phosphorylation | Kinase | EEF2K | O00418 | PSP |
500 | S | Phosphorylation | Kinase | PKA | - | Uniprot |
- | K | Ubiquitination | E3 ubiquitin ligase | BTRC | Q9Y297 | PMID:22669845 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of EF2K_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
FBW1A_HUMAN | BTRC | physical | 22669845 | |
SKP1_HUMAN | SKP1 | physical | 22669845 | |
EF2_HUMAN | EEF2 | physical | 22669845 | |
CDK1_HUMAN | CDK1 | physical | 18337751 | |
DENR_HUMAN | DENR | physical | 18337751 | |
ALBU_HUMAN | ALB | physical | 18337751 | |
ACADV_HUMAN | ACADVL | physical | 18337751 | |
MAP2_HUMAN | METAP2 | physical | 18337751 | |
PA2G4_HUMAN | PA2G4 | physical | 18337751 | |
IF4A3_HUMAN | EIF4A3 | physical | 18337751 | |
ARP2_HUMAN | ACTR2 | physical | 22863883 | |
CALR_HUMAN | CALR | physical | 22863883 | |
DPP9_HUMAN | DPP9 | physical | 22863883 | |
DUS3L_HUMAN | DUS3L | physical | 22863883 | |
PANK4_HUMAN | PANK4 | physical | 22863883 | |
KAP1_HUMAN | PRKAR1B | physical | 22863883 | |
RAGP1_HUMAN | RANGAP1 | physical | 22863883 | |
PRPK_HUMAN | TP53RK | physical | 22863883 | |
UBE3C_HUMAN | UBE3C | physical | 22863883 | |
SRP14_HUMAN | SRP14 | physical | 23455922 | |
SRP09_HUMAN | SRP9 | physical | 23455922 | |
RAE1L_HUMAN | RAE1 | physical | 23455922 | |
ACACA_HUMAN | ACACA | physical | 23455922 | |
WDFY3_HUMAN | WDFY3 | physical | 23455922 | |
FBW1B_HUMAN | FBXW11 | physical | 23455922 | |
FBW1A_HUMAN | BTRC | physical | 23455922 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"The channel-kinase TRPM7 regulates phosphorylation of thetranslational factor eEF2 via eEF2-k."; Perraud A.L., Zhao X., Ryazanov A.G., Schmitz C.; Cell. Signal. 23:586-593(2011). Cited for: PHOSPHORYLATION AT SER-78. | |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-18 AND SER-470, AND MASSSPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-18; SER-27; SER-31;SER-470 AND SER-474, AND MASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-18; THR-348; SER-470;SER-474 AND SER-477, AND MASS SPECTROMETRY. | |
"cdc2-cyclin B regulates eEF2 kinase activity in a cell cycle- andamino acid-dependent manner."; Smith E.M., Proud C.G.; EMBO J. 27:1005-1016(2008). Cited for: PHOSPHORYLATION AT SER-359. | |
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry."; Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.; Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-135, AND MASSSPECTROMETRY. | |
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization."; Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.; Nat. Biotechnol. 24:1285-1292(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-18 AND SER-445, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-18; SER-27; SER-31;TYR-69; SER-70; SER-470 AND SER-474, AND MASS SPECTROMETRY. | |
"Stimulation of the AMP-activated protein kinase leads to activationof eukaryotic elongation factor 2 kinase and to its phosphorylation ata novel site, serine 398."; Browne G.J., Finn S.G., Proud C.G.; J. Biol. Chem. 279:12220-12231(2004). Cited for: FUNCTION, AND PHOSPHORYLATION AT SER-398. | |
"Robust phosphoproteomic profiling of tyrosine phosphorylation sitesfrom human T cells using immobilized metal affinity chromatography andtandem mass spectrometry."; Brill L.M., Salomon A.R., Ficarro S.B., Mukherji M., Stettler-Gill M.,Peters E.C.; Anal. Chem. 76:2763-2772(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-18, AND MASSSPECTROMETRY. | |
"Regulation of elongation factor 2 kinase by p90(RSK1) and p70 S6kinase."; Wang X., Li W., Williams M., Terada N., Alessi D.R., Proud C.G.; EMBO J. 20:4370-4379(2001). Cited for: PHOSPHORYLATION AT SER-366 BY RPS6KA1 AND RPS6KB1, AND MUTAGENESIS OFSER-366. | |
"A novel method to identify protein kinase substrates: eEF2 kinase isphosphorylated and inhibited by SAPK4/p38delta."; Knebel A., Morrice N., Cohen P.; EMBO J. 20:4360-4369(2001). Cited for: PHOSPHORYLATION AT SER-359. |